CKAAKN peptide-conjugated long-circulating nanoliposomes for the targeted delivery of oridonin to pancreatic cancers.

Zhang F, Luo K, Xuan S, Chen T, Chen Z, Yang J, Zhou Y, Feng T, Zhu Y, Wang Z

DOI: 10.1038/s41598-026-36920-5
Published: 2026 Jan 23
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-36920-5,
  title = {CKAAKN peptide-conjugated long-circulating nanoliposomes for the targeted delivery of oridonin to pancreatic cancers.},
  author = {Zhang F and Luo K and Xuan S and Chen T and Chen Z and Yang J and Zhou Y and Feng T and Zhu Y and Wang Z},
  year = {2026},
  journal = {Scientific reports},
  doi = {10.1038/s41598-026-36920-5},
  url = {https://doi.org/10.1038/s41598-026-36920-5}
}

RIS

TY  - JOUR
TI  - CKAAKN peptide-conjugated long-circulating nanoliposomes for the targeted delivery of oridonin to pancreatic cancers.
AU  - Zhang F
AU  - Luo K
AU  - Xuan S
AU  - Chen T
AU  - Chen Z
AU  - Yang J
AU  - Zhou Y
AU  - Feng T
AU  - Zhu Y
AU  - Wang Z
PY  - 2026
JO  - Scientific reports
DO  - 10.1038/s41598-026-36920-5
UR  - https://doi.org/10.1038/s41598-026-36920-5
ER  -

APA

F, Z., K, L., S, X., T, C., Z, C., J, Y., Y, Z., T, F., Y, Z., & Z, W. (2026). CKAAKN peptide-conjugated long-circulating nanoliposomes for the targeted delivery of oridonin to pancreatic cancers.. Scientific reports. https://doi.org/10.1038/s41598-026-36920-5

Source records

pubmed · retrieved 2026-09-26T03:29:58.218Z